Chromadex Corp CS (CDXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CDXC | GLUE | ARCT | ||
| Company | Chromadex Corp CS | Monte Rosa Therapeutics Inc | Arcturus Therapeutics Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.46 | 6.90 | 15.49 | ||
| High | 5.51 | 7.18 | 16.83 | ||
| Low | 5.35 | 6.89 | 15.13 | ||
| Last | 5.37 | 7.08 | 16.21 | ||
| Change | -0.12 | +0.15 | +0.73 | ||
| % Change | -2.19% | +2.16% | +4.72% | ||
| Volume | 207,464 | 609,551 | 211,339 | ||
| 20-Day Average Volume | 705,558 | 1,832,032 | 396,083 | ||
| Previous Close | 5.49 | 6.93 | 15.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.64 | 8.52 | 17.21 | ||
| 20-Day Raw Stochastic | 5.14% | 19.35% | 26.81% | ||
| 20-Day Relative Strength | 40.73% | 44.07% | 43.10% | ||
| Weighted Alpha | +66.47 | -33.97 | -56.07 | ||
| Today's Opinion | 56% Buy | 56% Buy | 100% Sell | ||
| Previous Opinion | 56% Buy | 56% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.36% since 12/16/24 | -8.46% since 12/16/24 | -1.02% since 12/16/24 | ||
| Low | 5.25 on 12/20/24 | 6.15 on 12/19/24 | 14.30 on 12/19/24 | ||
| High | 6.14 on 12/17/24 | 7.95 on 12/17/24 | 16.85 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -27.55% since 11/22/24 | -17.20% since 11/22/24 | -4.94% since 11/22/24 | ||
| Low | 5.25 on 12/20/24 | 6.15 on 12/19/24 | 14.30 on 12/19/24 | ||
| High | 7.97 on 11/29/24 | 10.70 on 12/02/24 | 20.92 on 12/06/24 | ||
| 3-Month | |||||
| %Chg | +44.12% since 09/23/24 | +18.15% since 09/23/24 | -24.00% since 09/23/24 | ||
| Low | 3.18 on 10/10/24 | 4.59 on 10/09/24 | 14.30 on 12/19/24 | ||
| High | 7.97 on 11/29/24 | 12.40 on 10/28/24 | 25.88 on 10/02/24 | ||
| 6-Month | |||||
| %Chg | +97.44% since 06/21/24 | +93.66% since 06/21/24 | -41.44% since 06/21/24 | ||
| Low | 2.31 on 06/26/24 | 3.21 on 06/28/24 | 14.30 on 12/19/24 | ||
| High | 7.97 on 11/29/24 | 12.40 on 10/28/24 | 28.05 on 06/24/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 419,343 | 425,758 | 419,307 | ||
| Shares Outstanding, K | 76,383 | 61,437 | 27,087 | ||
| Annual Sales | 83,570,000 | 0 | 166,800,000 | ||
| Annual Net Income | -4,940,000 | -135,350,000 | -29,730,000 | ||
| Last Quarter Sales | 25,580,000 | 9,220,000 | 41,670,000 | ||
| Last Quarter Net Income | 1,880,000 | -23,860,000 | -6,900,000 | ||
| 60-Month Beta | 2.15 | 1.37 | 2.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.02 on 10/31/24 | -0.29 on 11/07/24 | -0.26 on 11/07/24 | ||
| Latest Earnings Date | 10/31/24 | 11/14/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 01/04/13 | ||
| Ratios | |||||
| Price/Earnings ttm | 549.00 | 0.00 | 0.00 | ||